Agoracom Blog Home

Posts Tagged ‘tsx’

Plant-based diets shine when looking at the gut health SPONSOR – Else Nutrition $BABY.ca $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 3:55 PM on Thursday, September 10th, 2020

SPONSOR: Else Nutrition Holdings Inc. (TSX-V: BABY) The award winning, plant-based nutrition company for small cap investors. The company has a $7,000,000 cash balance for US product launch with International agreements coming soon. Learn More.

http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Plant-based diets shine when looking at the gut health

  • Microbiome of the gut is created at birth, the study notes, but continues to develop throughout infancy and is significantly affected throughout childhood by diet
  • There is a large shift in the composition of the gut as infants are weaned and begin consuming solid foods, with the makeup of the gut resembling that of adults by about age 3 years

By: Rachael Zimlich, RN, BSN

A recent study investigating how foods impact gut health in children points to plant-based proteins, fresh fruits and vegetables, and grains as key to a diverse and healthy microbiome.

There has been a wealth of evidence collected on how important the gut microbiome is for health maintenance, but little research has been done on how diet habits are related to gut health in prepubescent children. A recent study took a closer look.

The study,1 published in the Journal of the Academy of Nutrition and Dietetics, reveals that gut health in young children and pre-pubescent teenagers is both dynamic and diverse, and is particularly responsive to certain food groups.

“The gut microbiome remains dynamic for children past 3 years of age and responds to dietary differences,” says lead author Dena Herman, PhD, MPH, RD, professor at California State University, Northridge and director of the MCH Nutrition Leadership Training Program at the UCLA Fielding School of Public Health. “This represents an opportunity to learn healthy habits early in life so that they can be sustained over the life course to maximize health.”

The health of the gut plays a vital role in maintaining health and supporting immune functions, the study notes. The microbiome is impacted by a number of factors, with individualized diets being one of the most important determinants of a diverse gut environment.

The microbiome of the gut is created at birth, the study notes, but continues to develop throughout infancy and is significantly affected throughout childhood by diet. There is a large shift in the composition of the gut as infants are weaned and begin consuming solid foods, with the makeup of the gut resembling that of adults by about age 3 years. Little research has been done on the makeup of the childhood gut between 3 years of age and the adolescent years, the study notes, but dietary patterns have been associated with significant differences in the guts of children in the age range of 4 to 8 years. As diets have shifted more toward a Western diet, heavily featuring highly processed foods and high-fat animal products, more and more diseases have been attributed to an imbalance in the microbial composition of the gut, the study reveals.

To examine how diet influenced gut health in the study group, researchers asked parents to collect fecal samples and quantitative 24-hour diet recalls, investigating each 3 times, each time about 6 days apart. The team examined how diet impacted gut health by splitting children into groups based on the types of food they consumed. Protein consumption—both animal- and plant-based—was the only food group that was associated with gut diversity. Total grain and vegetable consumption, on the other hand, heavily influenced the community makeup of the microbiome, the study notes. The research team noted some surprise here, in that yogurt was the only animal-derived food that was associated with the membership and structure of the microbiome. Instead, proteins were more closely linked to higher levels of diversity in the types of microorganisms found in the gut, the study states. The most abundant microorganisms found in the study groups were Bacteroides and Prevotella. The first was tied to Western diets, and the latter to fiber-rich diets.

Adequate diversity in the microbiome samples was noted, with results appropriate for the cohort’s age group. The research team found that older children in the study group had more diversity in their gut microbiomes, and that gender had no impact on the results. There were a number of trends noted with different food groups, such as lower diversity with a high non- whole-food grain consumption, and abundance of certain bacteria groups with higher consumption of fruit and fiber.

Overall, the study revealed that fresh fruits and vegetable consumption led to increased variation in the structure of the microbiome—with citrus, melon, and berries contributing most to gut diversity. Whole and non-whole grains were key to maintaining gut health, immune health, and glucose regulation, Herman stated. B-vitamins also played a big role in gut health, contributing to microbiome structure and composition, she says.

The 2- to 9-year-old group studied in this report is significant, because this represents a time when diets are becoming more diverse, and children begin to explore and become more independent in their eating habits. The study highlights the need to make this time count, the study notes, with guidance from adults on healthy eating habits to help promote good health and disease prevention in adulthood.

“Early and middle childhood may represent a crucial window when the gut microbiome might still be amenable to lasting manipulations through diet,” the study reveals.

The study emphasizes the importance of diet in the development of a healthy microbiome during the childhood years, with non-whole-grain foods enriched with vitamins and minerals being perhaps one of the largest contributors to gut health in this pilot sample.

“There are many benefits of a healthy gut for children. First and foremost, is an enhanced immune response. Young children are often more susceptible to upper respiratory tract infections and ear infections, especially if they are in childcare and as they enter school,” Herman explains. “By maintaining a diverse diet, children have a better chance of maximizing the healthy bacteria that can support immune health.”

The benefits of a healthy gut don’t end with physical health, she adds. Mental health effects were not the focus of the study, Herman says, but there has been prior research drawing a strong connection between gut health and brain health.

“For children this could translate into better focus in school allowing them to reach their academic potential. Unlike other studies, this study showed that children past 3 years of age are still able to change the structure and membership of their microbiome through the foods that they eat,” she says. “This is exciting and helps us extend the findings from studies in adults to children. The benefits described for children are similar for adults. However, as we age we have increased risk for inflammation, which can lead to higher rates of chronic diseases including cancers. That is why it is important to start healthy habits as early in life as possible.”

Although the study was small, it was more detailed than most previously conducted research examining gut health in children, she says. It highlights the benefits of plant-based diets, which Herman says she hopes will convince parents and clinicians to make changes—both for their children and themselves.

“I would hope that the results we have shared provide further support for the promotion of a plant-based diet—not only for young children, but also for adults. Parents are role models for their children’s eating habits and this study shows that we can actively engage in making positive changes to our gut health and overall health starting at a young age,” Herman says. “As a pediatric dietitian myself, I would hope that we could work together with the medical community, particularly pediatricians, to promote healthy habits including healthful eating habits and regular exercise through anticipatory guidance at all well-child visits. With the high rates of obesity in the United States, having children consume foods that support reduced risk for obesity may translate into lower risks for obesity-related diseases in adulthood such as cardiovascular disease and diabetes. Starting this practice as early as possible will ensure the most benefit for these children and generations to come.”

Reference

1. Herman D, Rhoades N, Mercado J, Argueta P, Lopez U, Flores G. Dietary habits of 2- to 9-year-old american children are associated with gut microbiome composition. J Acad Nutr Diet. 2020;120(4):517-534. doi:10.1016/j.jand.2019.07.024

Source: https://www.contemporarypediatrics.com/view/plant-based-diets-shine-when-looking-at-the-gut-microbiome

Kontrol’s $KNR $KNR.ca $KNR.c $KNRLF COVID-19 Technology Receives Positive Lab Results for Live COVID-19 Testing $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 3:29 PM on Thursday, September 10th, 2020
kontrol-logo

Kontrol BioCloud a Safe Space Technology™

  • Received positive lab results for BioCloud testing against the live virus that causes COVID-19
  • This positive result follows two successful tests against the dormant SARS-CoV-2 virus

This technology can improve our surveillance of SARS-CoV-2 by monitoring air quality in
multiple settings
.”

Dr. Jimmy D. Dikeakos, Ph.D

This technology will allow for measurement of many different viruses, bacteria, and fungi beyond the immediate need for the virus that causes COVID-19.”

Dr. David Heinrichs, Ph.D

TORONTO, ON / September 10, 2020 / Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Company“) is pleased to provide an update on its Kontrol BioCloud (or “BioCloud“) technology.

Lab Testing with Live Virus

Kontrol has received positive lab results for BioCloud testing against the live virus that causes COVID-19. This positive result follows two successful tests against the dormant SARS-CoV-2 virus (see press release dated August 10th, 2020 and press release dated August 27th, 2020).

“We are very pleased that through a methodical approach we have been able to successfully test our technology with the live virus causing COVID-19 and will turn our focus to commercialization of BioCloud,” says Paul Ghezzi, CEO of Kontrol. “It has been a long journey to get to this point since the initial concept design in March 2020 and through the great efforts of our team we look forward to delivering a safe space technology solution.”

This technology can improve our surveillance of SARS-CoV-2 by monitoring air quality in
multiple settings
.”

Dr. Jimmy D. Dikeakos, Ph.D

This technology will allow for measurement of many different viruses, bacteria, and fungi beyond the immediate need for the virus that causes COVID-19.”

Dr. David Heinrichs, Ph.D

Commercialization

Kontrol will begin the commercialization process of BioCloud by initiating an application to the CSA Group. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. Kontrol anticipates that a CSA approval can take from 30 to 45 days to complete and Kontrol has a history of working with CSA on various air quality and emission products. During the process of CSA approval, Kontrol will seek to establish lower detection limits of the COVID-19 virus. Lower detection limit specifications are part of the commercial specifications that Kontrol will deliver for a fully commercialized product.

We are very pleased to start the process of sharing our technology with the market through the commencement of commercialization,” says Gary Saunders, VP of Kontrol. “We want to thank our lab partners for all of their expertise and dedication. The lab procedures involved significant planning and preparation to execute meticulous testing against the live COVID-19 virus. We look forward to sharing our results with all levels of Government in the coming days and weeks ahead.”

Manufacturing Capacity

Kontrol has commenced discussions with two global outsource contract manufacturers who can provide Kontrol with external manufacturing capacity. Kontrol is not making any statements or assumptions about potential revenues, however, Kontrol is planning for up to 20,000 BioCloud units per month as manufacturing capacity. This is part of Kontrol’s prudent overall planning and access to manufacturing capability.

About Kontrol BioCloud

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

About Kontrol Energy

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.

Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.


Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.


For further information, contact:

Paul Ghezzi, Chief Executive Officer
[email protected] or [email protected]
Kontrol Energy Corp.,
180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8
Tel: 905.766.0400, Toll free: 1.844.566.8123

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

SOURCE: Kontrol Energy Corp.

Why #AI and #IoT will play a big role in retail of tomorrow – SPONSOR: Loop Insights Inc. $MTRX.ca $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 2:53 PM on Thursday, September 10th, 2020

SPONSOR: Loop Insights Inc. (MTRX:TSX-V) is levelling the playing field between online retail giants and brick & mortar businesses. What if you could receive the same personalization and experience you get from online shopping, but in brick and mortar stores? Loop Insights is doing just that. Brick and mortar retail isn’t going anywhere, but it does need to adapt to offer better in-store customer experiences. Loop Insights solves a significant problem for traditional retailers – big and small – who are losing customers to e-commerce retail. Learn more.

Loop Insights – Medium

Why AI and IoT will play a big role in retail of tomorrow

  • While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact
  • By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores

The pandemic has left irreversible changes within the retail industry as consumer behavior during a time of limited and regulated movement evolved. A PYMNTS 2020 Remote Payments Study reported that mobile devices are the most popular device for online shopping, with up to 72% of consumers using their mobile devices to shop. 

The explosion of online shopping saw an increase of 146% in online retail orders as of April 21, 2020 when compared to the same period last year. While e-commerce’s growth has accelerated by “four to six years” according to a recent report published by Adobe indicated that on the ground retailers are now embracing digital-first approaches in order to acclimate to the new norms of social distancing and minimized contact. By enlisting artificial intelligence (AI) and Internet of Things (IoT) solutions, the retail sector is implementing new approaches to enhance customer experience, drive sales, and, most importantly, ensure the safety of employees and retailers in stores.  

AI

AI applications can accommodate multiple retail scenarios; AI in the retail market is set to hit US$19.9 billion by 2027, with leading brands already placing AI in storefronts. 

Luxury department store Neiman Marcus makes it easier for customers to find items through visual search. The company’s Snap.find.shop. app is powered by AI, and it enables customers to seek items that match closely with photos they’ve taken. 

At Macy’s, customers can seek the assistance of the company’s On Call app for a better shopping experience. Macy’s On Call app is tailored with answers for specific stores. Customers can chat with an AI-backed bot for inventory checking and directions to navigate around the store. Interestingly, the AI bot is able to detect if a customer is getting frustrated and alert a store associate for help.

These projects were already well in place before the pandemic but will play a bigger role post-COVID, serving as an example for other retailers seeking to incorporate technology. These AI-inspired solutions are customer-centric and could potentially take over the role of store associates, which helps reduce the risks for retail employees at this time. 

IoT 

If AI solutions are adopted for enhanced services and to ease the burden of store personnel, IoT is then famed for their data-driven approaches to turbocharge core operations in retail. 

Recently, Auchan Retail Portugal, with a network of 34 supermarkets and hypermarkets across the European country, announced it would deploy a fleet of autonomous robots for optimized shelf monitoring. 

These autonomous robots will circle around the stores up to three times daily to capture photos of every shelf and aisle. The captured photos are then digitized at scale with computer vision and IoT, and then converted into reports with actionable insights for store staff to act upon. The reports delivered through a mobile app will boost store employees’ efficiency in managing, prioritizing, and resolving shelf issues.Andre Vieira, Digital Director at Auchan Retail Portugal, noted that “innovation, through the search for digital strategies, focused on people and improving customer service is one of Auchan’s great bets. With the introduction of autonomous robots, Auchan wants to improve productivity in stores, and optimize the supply chain, freeing employees to focus 100% on the mission of providing a better customer experience.”

Source: https://techhq.com/2020/08/why-ai-and-iot-will-play-a-big-role-in-retail-of-tomorrow/

Investing in #Palladium – Everything You Need to Know – SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 11:30 AM on Thursday, September 10th, 2020

Investing in Palladium – Everything You Need to Know

  • Auto Industry Demand – This is by far the number one influence on the prices of palladium around the world
  • Geopolitical Concerns – This factor can be active on a number of fronts for palladium and is something you should investigate prior to investing
  • Substitution – Substituting palladium for other metals within the auto industry is something which is coming under and increasing amount of scrutiny

By: Anthony Gallagher

Why Invest in Palladium?

Investing in precious metals you would be forgiven for putting a very heavy focus on the popular names in the sector. Trading in gold and silver obviously attracts much more attention in this area, mainly due to the general level of awareness that most people have around these very common market choices. There are other precious metals that are definitely worth investing in though. One of these which is often forgotten about by retail traders, is palladium. Despite the fact this precious metal has grown strongly in recent years, and has displayed gains of more than 1,000% since 2008, it is often left aside by investors focused on the higher volume gold and silver markets.

Here we will show you what the palladium market is all about, how you can get into trading this precious metal, and why it may be a great addition to your portfolio.

The Basics – What Drives Palladium Prices?

At the present time, palladium is trading higher than gold, with both at record high points. This has shone a light on both like never before. So, what are the main factors which have driven the prices of palladium to put them at higher levels even than gold? Here are a few major ones to consider:

Auto Industry Demand – This is by far the number one influence on the prices of palladium around the world. The auto industry accounts for around three quarters of the global demand for palladium. This is due to the fact that palladium is a key component in the manufacturing of catalytic converters. This, and particularly the demand for vehicles in large markets like the US and China have a huge bearing on the price of palladium.

Geopolitical Concerns – This factor can be active on a number of fronts for palladium and is something you should investigate prior to investing. Much of the world’s palladium supply comes from Russia, and South Africa. This accounts for about 80% of the total supply worldwide. With that said, any interruptions to this supply or process, be it in the form of sanctions as Russia sometimes deals with, or power supply problems, can cause a fluctuation in prices.

Substitution – Substituting palladium for other metals within the auto industry is something which is coming under and increasing amount of scrutiny. This is in large due to the high price of palladium, and also the fact that a number of substitutes, including platinum can be used. With that in mind though, platinum is not a direct substitute that can be easily used, so car makers are still largely reliant on palladium.

US Dollar Strength – The US Dollar forex market is going through a tough time currently. This weakening dollar can certainly have an impact on palladium prices as it does on other precious metals, though the reasoning behind it may be different. Palladium is typically purchased from suppliers in US Dollars. Any downward movement in the Dollar has potential to act as a disincentive top suppliers. This can reduce the supply of the precious metal which in turn can lead to an upward price movement.

Ways to Invest in Palladium

Now that you know several of the key drivers behind the price of palladium, it puts you in a good position to get involved in buying and trading the market. There are several ways in which you can do this much trading gold or silver markets. The main points which will vary here are the liquidity, and how closely the investment is tied to the palladium price.

The most direct way to get involved in trading palladium is to purchase palladium bullion directly from a reputed mint or other trustworthy supply source. This physical purchase of the metal typically takes the form of coins, collectable coins, or bars of the metal which can be purchased at different weights. Naturally, this is absolutely tied to the palladium market prices, though you should be mindful that a small premium is generally added by the seller, and this can be a substantially more difficult palladium investment to resell quickly if the price changes.

Palladium stocks are another popular way to get involved in trading the market. This means buying stocks in palladium related companies through your broker. They are typically very closely connected to the demand and price for palladium, though you also have to be careful to understand the key metrics of the individual company performance too. If you are looking for an even higher volume market, you may choose to trade palladium options or futures contracts. These can be higher risk, but are certainly the most liquid in terms of your ability to quickly trade palladium.

Finally, if you are seeking a very well-balanced way to invest in palladium, ETFs may be a good choice for you. There are essentially baskets of stocks which you can invest in at one collective price. Investing in a thematic ETF related to palladium will give you good exposure to many of the main players in the sector, and should also hedge your risk to a certain extent if the prices do fall. These ETFs can often pay a healthy dividend too.

Who Should Invest in Palladium?

Although palladium is now at a higher price point than gold, it is still very much an investment that any type of trader can make. Like other precious metal investments, it is something you can use to add great diversity to your portfolio. It is also becoming very accessible to all retail traders thanks to being on offer from many of the top online brokers.

Your investment in palladium really depends on your risk profile. This will determine which method of palladium investment may be most suitable for you. If you are willing to take more risk and can withstand a degree of volatility, you may consider options, or futures, while a more conservative approach would be an investment in ETFs or certain index funds. With the growth in demand and price though, it is clear that more and more traders are becoming aware of the potential within trading palladium as much as other precious metals.

Source: https://www.securities.io/investing-in-palladium-everything-you-need-to-know/

DataMetrex $DM.ca Secures Contract with 7-Eleven

Posted by AGORACOM-JC at 8:14 AM on Thursday, September 10th, 2020
Webinar logo
  • Announced that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation infrastructure.
  • RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process
  • Global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period

Toronto, Ontario–(September 10, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex“) is pleased to announce that it has entered into a sales agreement with 7-Eleven Korea for Robotic Process Automation (“RPA”) infrastructure.

The global RPA market size is expected to reach $7.2 billion by 2025, rising at a market growth of 32.6% CAGR during the forecast period. RPA is the technology that enables anyone to configure computer software today, or a “robot” to replicate and incorporate the actions of a person working within digital systems to conduct a business process. An increased demand for business process automation (“BPA”) is expected to be the main growth driver through the use of Artificial Intelligence (“AI”) and RPA.[1]

7-Eleven is a international chain of convenience stores founded in 1927 in the United States with over 70,000 stores located around the globe. 7-Eleven has a legacy of innovation and delivering “what the customers want, when and where they want it.”

Datametrex is working closely with clients to power it through their digital initiatives and improve their delivery on innovation as they continue the pursuit of catering to a modern, digital-savvy generation of shoppers.

“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. Our technology is proven to be valuable to make sense of the data beyond complicated spreadsheets.” said Marshall Gunter, CEO of Datametrex. “We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data. Through predictive analysis they can support their decision making, mitigate risk, and improve their bottom line.”

Investor Webinar

Datametrex also announces that senior management will be hosting an investor update webinar on Tuesday, September 15, 2020, at 1:00 p.m. ET to discuss the Company’s Second Quarter 2020 results, developments and contracts on the Artificial Intelligence technologies and COVID-19 test kits.

Webinar Details:

Date: Tuesday, September 15, 2020

Time: 1:00 p.m. ET

Registration Link: https://us02web.zoom.us/webinar/register/WN_FZc3a5nlQiKlsTEq5bqFfQ?t=1599612433950

Datametrex plans to answer questions previously sent to [email protected] and during the webinar, at management’s discretion and subject to time constraints.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.____________________________________

[1] Source: Global Robotic Process Automation Market By Component By Organization Size By Deployment Type By End User By Region, Industry Analysis and Forecast, 2019 – 2025NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

EVENT: You’re invited to Datametrex $DM.ca Investor Webinar on September 15th @ 1 PM EST.

Posted by AGORACOM-JC at 1:18 PM on Wednesday, September 9th, 2020
Webinar logo

You’re invited to our Investor Webinar on September 15th @ 1 PM EST. We will be discussing the Q2 financials, and the following topics: COVID-19 Testing and AI technology.

Please click the link below to register: 

https://us02web.zoom.us/webinar/register/WN_FZc3a5nlQiKlsTEq5bqFfQ

MedX Health Corp. $MDX.ca Announces Management Changes and Increased Focus on SIAscopy™ on DermSecure™ $DMTK $ICAD $PLSE $SRTS

Posted by AGORACOM-JC at 8:20 AM on Wednesday, September 9th, 2020
Home - MedX Health
  • Completed management changes to enhance its focus on its dermatological services and products including DermSecure™ and SIAscopy™
  • Mike Druhan, who has championed SIAscopy™ within the Company for a number of years, has been appointed President, Dermatological Services and Products.

MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced that it has completed management changes to enhance its focus on its dermatological services and products (“DSP”) including DermSecure™ and SIAscopy™.

Mike Druhan, who has championed SIAscopy™ within the Company for a number of years, has been appointed President, Dermatological Services and Products. The supporting teams in sales, training, production as well as software and hardware development for DSP will report to Mr. Druhan. “Mike and his team will continue to build out the Brazilian, Canadian and Dutch markets where we have established sales but more importantly, this refocus will allow more resources to be devoted to our initiatives in the United States, Latin America and Europe,” said Rob von der Porten, Executive Chair and interim CEO.

“I have full confidence in the capability of my team and the outstanding strengths of our technologies, SIAscopy™ and DermSecure™, which together form, in our view, the leading teledermatological offering in the world,” noted Mike Druhan. “As we have already seen, it saves lives and has a huge potential that we are starting to exploit. Consequently, we are relaunching the MedX website in the coming week, with much improved content on our dermatological focus, in keeping with our driving strategy,” he continued.

Louie Canitano, who has many years of experience in therapeutic laser and light products has been appointed Managing Director Light Therapy Products, with responsibility over sales of these products in Canada and the United States. He will work with our Canadian and US-based sales and distributor network.

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy™ on DermSecure™ telemedicine platform, utilizing its SIAscopy™ technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality light therapy products, including therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company’s limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company’s projections or forward-looking statements. All forward looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Rob von der Porten
MedX Health Corp
[email protected]

Hilaria Baldwin Joins Else Nutrition $BABY.ca as a Brand Ambassador for Plant-Based Toddler Nutrition Launch in U.S. $KMB $BMY $ABT $WYE

Posted by AGORACOM-JC at 7:16 AM on Wednesday, September 9th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin
  • Baldwin has joined Else Nutrition as part of its U.S. launch marketing efforts around its Complete Toddler Nutrition

VANCOUVER, BC / September 9, 2020 / Else Nutrition Holdings (TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company”), is pleased to announce its partnership with celebrity author, podcast host and parenting expert, Hilaria Baldwin. Baldwin has joined Else Nutrition as part of its U.S. launch marketing efforts around its Complete Toddler Nutrition.

As a mom who has always advocated a plant-based lifestyle, the collaboration originated from Hilaria’s own search for a suitable toddler formula alternative for her children. Baldwin will help Else through creative social media and video content that highlights her findings and journey as a plant-based mother.

“Hilaria embodies our brand values through her desire to take baby nutrition to the next level with a heightened awareness for health and wellness,” said Mrs. Hamutal Yitzhak, CEO and Co-Founder of Else. “She is a true champion of the cause, which makes us beyond excited about this collaboration. Together, we hope to raise awareness of the benefits of clean-label, plant-based baby nutrition for this generation and the future ones to come.”

“I am thrilled to be partnering with Else Nutrition. As many of you know, my family primarily eats a dairy-free, plant-based diet. I nurse my babies and am always looking for a plant-based toddler formula to transition to once they are weaned. There hasn’t been anything suitable except soy until now. Else is complete, whole Nutrition and my toddler Romeo genuinely loves it. It’s really the alternative that I had been looking for, and I believe that so many other parents like myself have been longing for it as well,” said Mrs. Hilaria Baldwin.

Most recently, Else made its debut on national U.S. television. Baldwin appeared on E!’s popular midday show, Daily Popwhere she explained why Else is her choice for her toddler, Romeo. Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is available for order on Else’s e-store at elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QB board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

About Hilaria Baldwin

Hilaria Baldwin (@hilariabaldwin) is the Co-Host of Mom Brain, Apple’s #1 parenting podcast; the author of The Living Clearly Method: 5 Principles for a Fit Body, Healthy Mind & Joyful Life (Rodale; December 2016); and Co-Founder of Yoga Vida in NYC. She is also a monthly contributor to TODAY.com’s One Small Thing platform and to People’s People Parents Squad. Hilaria lives in NYC with her husband Alec and their four children, Carmen Gabriella, Rafael Thomas, Leonardo Angel and Romeo Alejandro David, and they’re currently expecting their fifth child.

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

For additional information, contact:

Ms. Hamutal Yitzhak, CEO, Co-Founder & Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: +972(0)3-6445095

Mr. Sokhie Puar, Director
ELSE Nutrition Holdings Inc.
E: [email protected]
P: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the Company’s anticipated partnership with Mrs. Baldwin. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others Forward-looking statements made in this press release assume, among others, the successful partnership between the Company and Mrs. Baldwin. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Else Nutrition Holdings

ImagineAR $IP.ca $IPNFF Signs Five Year $250,000 USD Licensing Agreement with WaV Sports & Entertainment $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:12 AM on Wednesday, September 9th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Contract Revenue is $250,000 USD Plus 5 Year Joint Partnership Program Revenue Fees
  • Licensing agreement to provide its Augmented Reality Platform to WaV Sports & Entertainment for the launch of their new proprietary line of global sports engagement products
  • In addition to the five-year licensing fee, the agreement also provides for joint revenue sharing fees over the term which can significantly increase the annual revenue for ImagineAR

VANCOUVER, BC and ERIE, Pa., Sept. 9, 2020 – Imagine AR Inc. (CSE: IP) (OTCQB: IPNFF) (“ImagineAR” or “Company”) is excited to announce the signing of a five year $250,000USD licensing agreement to provide its Augmented Reality Platform to WaV Sports & Entertainment for the launch of their new proprietary line of global sports engagement products. In addition to the five-year licensing fee, the agreement also provides for joint revenue sharing fees over the term which can significantly increase the annual revenue for ImagineAR.

Brian Klaasmeyer, Co-Founder & Managing Partner of WaV Sports & Entertainment stated “Our partnership with ImagineARTM is going to address the new paradigm required today in professional sports for fan engagement and activation.  The ImagineAR augmented reality platform is truly a gamechanger for sports organizations and athletes to deliver in-home mobile phone engagement and drive consistent recurring monthly revenue for them. We are extremely optimistic that with our experienced executive team, we will generate significant revenue for our clients for years.”

Dean Dalton, Co-Found & Managing Partner of WaV Sports & Entertainment, and former NFL Minnesota Vikings Coach added “We have been analyzing new technologies and platforms for revolutionizing sports and fan engagement. Augmented Reality has been one of our keystone requirements and the ImagineAR platform is years ahead of every other company today.” 

Alen Paul Silverrstieen, CEO of ImagineAR, stated “Our new advisor, Gus Frerotte, introduced the founders of WaV Sports and Entertainment to ImagineAR as he realized the potential of a partnership for both organizations.  We believe the WaV Sports fan engagement business model and current relationships are going to be a catalyst for driving significant revenue for ImagineAR in 2020 and for the duration of the five-year agreement.” 

This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

ABOUT WaV Sports & Entertainment

WaV Sports & WaV Sports & Entertainment is a global sports marketing firm that specializes in sports property representation, brand side representation, and the management and production of unique sporting and entertainment events.  WaV exclusively represents the NFL Alumni Academy and various other NFL Alumni projects such as their youth educational programming known as Pro Day Experience.  WaV Sports & Entertainment has partnered with ImagineAR to expand their reach into the world of sports. Additional information on the Company can be found at www.WaVsports.com

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables sports organizations and businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

For more information or to explore working with Imagination Park, please email [email protected], or visit www.imagineAR.com.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by Imagination Park’s management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

July #Cannabis Sales Surge in 5 Western States – SPONSOR: Hollister Biosciences $HOLL.ca $WEED.ca $CGC $ACB $APHA $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 5:08 PM on Tuesday, September 8th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated Cannabis company with products in 230 California dispensaries, over 80 dispensaries throughout Arizona, joint ventures, licensing agreements and partnerships with Global brands. Revenue generated for the three-month period ended June 30th, 2020 was USD $8.47 million. Learn More

July Cannabis Sales Surge in 5 Western States

  • In July 2020, cannabis sales for state licensed retailers and delivery services reached $334.4 million, growing 15 percent from the trailing month and 26 percent compared to July 2019.
  • Year to date, sales in California have reached $1.9 billion, a 14 percent increase compared to the same period in 2019.
A Detailed Look at Cannabis Sales in California, Oregon, Arizona, Colorado and Nevada

Data provided by BDSA indicates that cannabis sales continued their robust expansion in 5 Western states. During July, the eleventh month after the onset of the vaping crisis and the fifth month of the pandemic impacting the market, sales across the five markets totaled $842.8 million, up 12% from June, which sequential increases of 2% in May and 14% in April. March had spiked to $666.0 million from $579.9 million in February as customers purchased cannabis ahead of store closures and concerns about limitations on access, so clearly cannabis sales are back on track. With the near-term effects of the pandemic now behind us, it’s clear that cannabis demand is surging, even in relatively mature markets, like Oregon and Colorado. Nevada continued to recover as tourism slowly returns, with sales growing 23%. California stood out with 15% sequential growth, while Colorado expanded 13%. Oregon sales climbed 6% and Arizona by 3%, but both of these states had meteoric growth from a year ago. July had one more day than June, which has the effect of adding 3% roughly.

Overall sales growth from a year ago among the five Western markets ranged from 26% in California to as high as 54% in Arizona. Nevada has been impacted by the tourist slowdown but still grew 37% from a year ago. Oregon continued its strong growth, rising 44%, while Colorado grew 35%. Concentrates represented 22-37% of sales by market, below the 26-38% share of sales last August before the vaping crisis hit.

Here is a closer look at each market, as detailed by BDSA:

Arizona

In July 2020, cannabis sales in Arizona’s medical dispensaries reached $94.2 million, growing three percent from June and over 54 percent compared to the previous July. Year-to-date through July, sales have reached $589.2 million, increasing by $194.5 million and 49 percent compared to the same period last year.

Flower sales accounted for nearly 48 percent of overall revenue for the month with $44.8 million in sales, growing one percent from June. Pre-rolled Joints, which are tracked as a separate category, accounted for just under four percent of revenue with $3.5 million in sales. Compared to the previous July, Flower sales increased by 52 percent and Pre-rolled Joints increased by 83 percent.

Concentrate sales accounted for about 37 percent of overall revenues with sales totaling $34.6 million in July, increasing six percent from the trailing month. Vape products, the largest segment of the Concentrates category, generated $21.8 million in sales, accounting for 63 percent of the Arizona Concentrates market and over 23 percent of sales across all categories. Compared to July 2019, sales of Dabbable Concentrates grew by 92 percent, while Vape sales grew by 46 percent.

The Ingestibles category accounted for nearly 11 percent of sales in July with $10 million in revenue for the month. Compared to July 2019 and June 2020, sales in the category grew by 47 percent and by four percent, respectively. In July, the $9.3 million in sales from Edibles generated nearly 93 percent of Ingestibles sales overall, while Sublinguals made up the remaining seven percent. Compared to the previous July, Edibles sales increased by 59 percent and Sublingual sales decreased by 30 percent.

California

BDSA sales reporting for the month of July reflects the state market of 699 licensed dispensary locations and 306 delivery operators.

In July 2020, cannabis sales for state licensed retailers and delivery services reached $334.4 million, growing 15 percent from the trailing month and 26 percent compared to July 2019. Year to date, sales in California have reached $1.9 billion, a 14 percent increase compared to the same period in 2019.

Sales from Flower generated $136.2 million in July 2020, accounting for nearly 41 percent of overall revenues. Compared to the trailing month and July 2019, Flower sales grew by 17 percent and 53 percent, respectively. Pre-rolled Joints, which are tracked as a separate category, accounted for nearly 11 percent of overall July revenues, with $35.6 million in sales.

Concentrates were the second-largest revenue category in July 2020, reaching $101 million in sales and accounting for over 30 percent of total revenue. Compared to the trailing month and July 2019, sales increased by 13 percent and by four percent, respectively. The $76 million in Vape sales accounted for over 75 percent of the Concentrates category and 23 percent of the month’s overall sales revenue.

In July 2020, Ingestibles generated $50.8 million in sales, increasing by 11 percent from the trailing month. Compared to July 2019, sales of Ingestibles grew by nearly 21 percent. Edibles contributed 86 percent of Ingestibles revenue, while Sublinguals made up the remaining 14 percent. Compared to July 2019, the Edibles and Sublinguals categories grew by 32 percent and declined by 22 percent, respectively.

Colorado

July 2020 was another milestone for the Colorado cannabis market. Sales in Colorado’s adult-use and medical dispensaries reached a combined $226.8 million, growing 13 percent from June. Compared to the previous July, sales increased by nearly 35 percent. Adult-use sales grew by 33 percent from July 2019 while medical sales grew by 41 percent. Year-to-date through July, combined channel sales have reached over $1.2 billion, increasing 22 percent from the same period last year.

In July, Flower sales accounted for over 47 percent of total monthly revenues, totaling at $107.2 million. Flower sales increased nearly 11 percent from the trailing month and grew 56 percent from the previous July. Year-to-date sales have increased by 40 percent in the category over the same period last year. Pre-rolled Joints, which are tracked separately from Flower, generated $13.2 million in sales for July 2020, growing 31 percent from July 2019 and increasing 17 percent from the trailing month.

The $66.5 million in Concentrate sales during July 2020 represented an 18 percent increase from the previous year and 15 percent growth from the trailing month. The category accounted for over 29 percent of revenue for the month. Vape products, the largest segment within the Concentrates category, reached $32.9 million in July sales, increasing 19 percent compared to June and four percent from the previous July, respectively. The Vape category accounted almost 50 percent of Concentrates’ revenue and 15 percent of overall sales for the month.

In July 2020, sales from Ingestibles generated $34.7 million, a 27 percent increase from July 2019. Compared to the trailing month, sales in the category grew by 17 percent. Edibles generated $32.7 million in monthly sales revenue, contributing over 94 percent to category sales and 14 percent of total revenue for the month. Sublinguals made up the remaining six percent of Ingestibles sales, totaling $1.9 million for the month.

Nevada

In July, Nevada dispensaries generated $82 million in sales. Compared to July of 2019, sales grew by 37 percent and by nearly 23 percent compared to the trailing month. Year-to-date through July, sales have reached $421.9 million, growing by six percent compared to the same period last year.

Flower sales accounted for nearly 54 percent of overall July 2020 sales. Sales in the category reached $44.1 million for the month, growing 27 percent from June. Pre-rolled Joints, tracked separately from Flower, accounted for nearly 11 percent of July sales, with $8.8 million in revenue. Compared to July 2019, Flower and Pre-rolled Joints sales have increased by 75 percent and by two percent, respectively.

Concentrate sales in July reached $18.3 million, accounting for more than 22 percent of overall revenue for the month. Compared to the trailing month as well as to the previous July, category sales increased by 17 percent. Vape products, the largest segment in the Concentrates category, generated $13.3 million for the month, contributing nearly 73 percent to Concentrates revenue and over 16 percent to total monthly sales.

Sales in the Ingestibles category accounted for 11 percent of all revenues, totaling $9.1 million in July sales and growing by about seven percent from the previous year. Compared to June, category sales grew by 17 percent. Edibles made up 90 percent of the Ingestibles category, reaching $8.2 million in July revenue, and Sublingual sales contributed the remaining ten percent.

Oregon

In July 2020, cannabis sales in Oregon’s medical and adult-use dispensaries reached a combined $106 million. Compared to the trailing month, sales in the Oregon market grew by about six percent, while compared to July 2019, sales grew by 45 percent overall. Year-to-date sales in Oregon have reached $620.3 million, growing by 39 percent compared to the same period in 2019.

Sales of Flower generated $50.3 million in July 2020, accounting for 47 percent of overall revenues. Compared to the trailing month, Flower sales grew by four percent, and compared to July 2019, sales increased by 65 percent. Pre-rolled Joints, which are tracked as a separate category, accounted for nine percent of overall revenues with $9.8 million in sales.

Concentrates generated $27.7 million in July sales. Compared to the trailing month and July 2019, sales in the category increased five percent and just over 25 percent, respectively. Vape products, the largest segment in the Concentrates category, generated $15 million in July, contributing over 54 percent of Concentrates sales and more than 14 percent of total monthly revenue.

In July 2020, Ingestibles generated over $14.6 million in sales, a nine percent increase from the previous month and nearly 25 percent compared to July 2019. Edibles, which made up 83 percent of the Ingestibles category and more than 11 percent of overall monthly sales, generated $12 million in July 2020.

For readers looking for a deeper look at cannabis markets across these five states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how the BDSA GreenEdge Platform can provide you with unlimited access to the most accurate and actionable data and analysis.

Source: https://www.newcannabisventures.com/july-cannabis-sales-surge-in-5-western-states/